These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 10934779)
21. Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats. Dhir A; Akula KK; Kulkarni SK Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):835-43. PubMed ID: 18234412 [TBL] [Abstract][Full Text] [Related]
22. Role of neurosteroids in experimental 3-nitropropionic acid induced neurotoxicity in rats. Kumar P; Kumar P; Khan A; Deshmukh R; Lal Sharma P Eur J Pharmacol; 2014 Jan; 723():38-45. PubMed ID: 24333475 [TBL] [Abstract][Full Text] [Related]
23. Brain enzyme and clinical alterations induced in rats and mice by nitroaliphatic toxicants. Gould DH; Wilson MP; Hamar DW Toxicol Lett; 1985 Sep; 27(1-3):83-9. PubMed ID: 4060188 [TBL] [Abstract][Full Text] [Related]
24. Rhes, a key element of selective neuronal vulnerability in Huntington's disease: a striatal-specific license to kill during energy metabolism failure. Ghiglieri V; Calabresi P Mov Disord; 2013 Jun; 28(6):735. PubMed ID: 23712467 [No Abstract] [Full Text] [Related]
25. Absorption of 3-nitropropanol and 3-nitropropionic acid from the digestive system of sheep. Pass MA; Majak W; Muir AD; Yost GS Toxicol Lett; 1984 Oct; 23(1):1-7. PubMed ID: 6485010 [TBL] [Abstract][Full Text] [Related]
26. Protective effect of Convolvulus pluricaulis standardized extract and its fractions against 3-nitropropionic acid-induced neurotoxicity in rats. Malik J; Choudhary S; Kumar P Pharm Biol; 2015; 53(10):1448-57. PubMed ID: 25853968 [TBL] [Abstract][Full Text] [Related]
27. A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease. Keene CD; Rodrigues CM; Eich T; Linehan-Stieers C; Abt A; Kren BT; Steer CJ; Low WC Exp Neurol; 2001 Oct; 171(2):351-60. PubMed ID: 11573988 [TBL] [Abstract][Full Text] [Related]
29. Presence of 3-nitropropionic acid, in widely distributed pasture legumes in Britain. Simpson DJ; Wainwright SJ; Hipkin CR Vet Rec; 1999 Aug; 145(6):169-71. PubMed ID: 10466775 [No Abstract] [Full Text] [Related]
30. 17 beta-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington's disease in ovariectomized rats. Túnez I; Collado JA; Medina FJ; Peña J; Del C Muñoz M; Jimena I; Franco F; Rueda I; Feijóo M; Muntané J; Montilla P Neurochem Int; 2006 Apr; 48(5):367-73. PubMed ID: 16420966 [TBL] [Abstract][Full Text] [Related]
31. Limited-time exposure to mitochondrial toxins may lead to chronic progressive neurodegenerative diseases. Beal MF Mov Disord; 2000 May; 15(3):434-5. PubMed ID: 10830405 [No Abstract] [Full Text] [Related]
32. Neuroprotective role of PDE4 and PDE5 inhibitors in 3-nitropropionic acid induced behavioral and biochemical toxicities in rats. Thakur T; Sharma S; Kumar K; Deshmukh R; Sharma PL Eur J Pharmacol; 2013 Aug; 714(1-3):515-21. PubMed ID: 23831390 [TBL] [Abstract][Full Text] [Related]
33. Melatonin protects against behavioural dysfunctions and dendritic spine damage in 3-nitropropionic acid-induced rat model of Huntington's disease. Chakraborty J; Nthenge-Ngumbau DN; Rajamma U; Mohanakumar KP Behav Brain Res; 2014 May; 264():91-104. PubMed ID: 24509309 [TBL] [Abstract][Full Text] [Related]
34. Effects of riluzole on combined MPTP + 3-nitropropionic acid-induced mild to moderate striatonigral degeneration in mice. Diguet E; Fernagut PO; Scherfler C; Wenning G; Tison F J Neural Transm (Vienna); 2005 May; 112(5):613-31. PubMed ID: 15503195 [TBL] [Abstract][Full Text] [Related]
35. Neuroprotective activity of L-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum. Thangarajan S; Deivasigamani A; Natarajan SS; Krishnan P; Mohanan SK Int J Neurosci; 2014 Sep; 124(9):673-84. PubMed ID: 24325390 [TBL] [Abstract][Full Text] [Related]
36. Quantitative determination of 3-nitropropionic acid and 3-nitropropanol in plasma by HPLC. Muir AD; Majak W Toxicol Lett; 1984 Feb; 20(2):133-6. PubMed ID: 6695403 [TBL] [Abstract][Full Text] [Related]
37. Assessment of 3-nitropropionic acid-evoked peripheral neuropathy in rats: neuroprotective effects of acetyl-l-carnitine and resveratrol. Binienda ZK; Beaudoin MA; Gough B; Ali SF; Virmani A Neurosci Lett; 2010 Aug; 480(2):117-21. PubMed ID: 20542088 [TBL] [Abstract][Full Text] [Related]
38. Neuroprotective effect of lutein against 3-nitropropionic acid-induced Huntington's disease-like symptoms: possible behavioral, biochemical, and cellular alterations. Binawade Y; Jagtap A J Med Food; 2013 Oct; 16(10):934-43. PubMed ID: 24138168 [TBL] [Abstract][Full Text] [Related]
39. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations. Kumar P; Kumar A Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928 [TBL] [Abstract][Full Text] [Related]
40. Discriminative behavioral assessment unveils remarkable reactive astrocytosis and early molecular correlates in basal ganglia of 3-nitropropionic acid subchronic treated rats. Cirillo G; Maggio N; Bianco MR; Vollono C; Sellitti S; Papa M Neurochem Int; 2010 Jan; 56(1):152-60. PubMed ID: 19799953 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]